In vivo assessment of cardiac metabolism and function in the abdominal aortic bandingmodel of compensated cardiac hypertrophy

被引:36
|
作者
Seymour, Anne-Marie L. [1 ]
Giles, Lucia [2 ]
Ball, Vicky [2 ]
Miller, Jack J. [2 ]
Clarke, Kieran [2 ]
Carr, Carolyn A. [2 ]
Tyler, Damian J. [2 ]
机构
[1] Univ Hull, Sch Biol Biomed & Environm Sci, Kingston Upon Hull HU6 7RX, N Humberside, England
[2] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England
基金
英国工程与自然科学研究理事会;
关键词
Dynamic nuclear polarization; Cardiac hypertrophy; Metabolic remodelling; Pyruvate dehydrogenase; C-13 magnetic resonance spectroscopy; C-13; MAGNETIC-RESONANCE; PYRUVATE-DEHYDROGENASE ACTIVITY; HYPERTHYROID RAT-HEART; HIGH-FAT DIET; PRESSURE-OVERLOAD; FAILING HEART; CONTRACTILE DYSFUNCTION; OXIDATIVE-METABOLISM; ENERGY-METABOLISM; WESTERN DIET;
D O I
10.1093/cvr/cvv101
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Left ventricular hypertrophy is an adaptive response of the heart to chronic mechanical overload and can lead to functional deterioration and heart failure. Changes in cardiac energy metabolism are considered as key to the hypertrophic remodelling process. The concurrence of obesity and hypertrophy has been associated with contractile dysfunction, and this work therefore aimed to investigate the in vivo structural, functional, and metabolic remodelling that occurs in the hypertrophied heart in the setting of a high-fat, high-sucrose, Western diet (WD). Methods and results Following induction of cardiac hypertrophy through abdominal aortic banding, male Sprague Dawley rats were exposed to either a standard diet or aWD(containing 45% fat and 16% sucrose) for up to 14 weeks. Cardiac structural and functional characteristics were determined by CINE MRI, and in vivo metabolism was investigated using hyperpolarized C-13-labelled pyruvate. Cardiac hypertrophy was observed at all time points, irrespective of dietary manipulation, with no evidence of cardiac dysfunction. Pyruvate dehydrogenase flux was unchanged in the hypertrophied animals at any time point, but increased incorporation of the C-13 label into lactate was observed by 9 weeks and maintained at 14 weeks, indicative of enhanced glycolysis. Conclusion Hypertrophied hearts revealed little evidence of a switch towards increased glucose oxidation but rather an uncoupling of glycolytic metabolism from glucose oxidation. This was maintained under conditions of dietary stress provided by aWD but, at this compensated phase of hypertrophy, did not result in any contractile dysfunction.
引用
收藏
页码:249 / 260
页数:12
相关论文
共 50 条
  • [31] The use of microPET/CT imaging of rodents to quantify cardiac perfusion and metabolism as a function of cardiac hypertrophy and age
    Janabi, Mustafa
    O'Neil, James P.
    Brennan, Kathleen
    Seo Youngho
    Gullberg, Grant T.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 : S157 - S157
  • [32] The experimental model of transition from compensated cardiac hypertrophy to failure created by transverse aortic constriction in mice
    Furihata, Takaaki
    Kinugawa, Shintaro
    Takada, Shingo
    Fukushima, Arata
    Takahashi, Masashige
    Homma, Tsuneaki
    Masaki, Yoshihiro
    Tsuda, Masaya
    Matsumoto, Junichi
    Mizushima, Wataru
    Matsushima, Shouji
    Yokota, Takashi
    Tsutsui, Hiroyuki
    IJC HEART & VASCULATURE, 2016, 11 : 24 - 28
  • [33] MRI/MRS assessment of in vivo murine cardiac metabolism, morphology, and function at physiological heart rates
    Chacko, VP
    Aresta, F
    Chacko, SM
    Weiss, RG
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 279 (05): : H2218 - H2224
  • [34] ASSESSMENT OF CARDIAC RISK BEFORE ABDOMINAL AORTIC-SURGERY - REPLY
    BARON, JF
    NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (07): : 480 - 480
  • [35] VARIATION WITH SPECIES OF THE RYANODINE RECEPTORS IN COMPENSATED CARDIAC-HYPERTROPHY
    RANNOU, F
    BEUVE, CS
    OLIVIERO, P
    CHARPENTIER, F
    CHARLEMAGNE, D
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1992, 24 : S27 - S27
  • [36] ENHANCED NUCLEAR RSK1 SIGNALLING PROMOTES CARDIAC HYPERTROPHY IN MICE IN VIVO, BUT COMPROMISES COMPENSATED HYPERTROPHY INDUCED BY PHENYLEPHRINE
    Clerk, Angela
    Rostron, Kerry
    Meijles, Daniel
    Fuller, Stephen
    Sugden, Peter
    HEART, 2018, 104 : A72 - A72
  • [37] Role of microtubules in the transition from compensated cardiac hypertrophy to failure
    Tsutsui H.
    Tagawa H.
    Cooper IV G.
    Takeshita A.
    Heart Failure Reviews, 1999, 4 (4) : 311 - 318
  • [38] Myocardial and coronary effects of propofol in rabbits with compensated cardiac hypertrophy
    Ouattara, A
    Langeron, O
    Souktani, R
    Mouren, S
    Coriat, P
    Riou, B
    ANESTHESIOLOGY, 2001, 95 (03) : 699 - 707
  • [39] In chronic kidney disease altered cardiac metabolism precedes cardiac hypertrophy
    Williams, Matthew J.
    Halabi, Carmen M.
    Patel, Hiral M.
    Joseph, Zachary
    Mccommis, Kyle
    Weinheimer, Carla
    Kovacs, Attila
    Lima, Florence
    Finck, Brian
    Malluche, Hartmut
    Hruska, Keith A.
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2024, 326 (05) : F751 - F767
  • [40] Ameliorative Role of Fluconazole Against Abdominal Aortic Constriction-Induced Cardiac Hypertrophy in Rats
    Shoieb, Sherif M.
    Alammari, Ahmad H.
    Levasseur, Jody
    Silver, Heidi
    Dyck, Jason R. B.
    El-Kadi, Ayman O. S.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (06) : 833 - 845